Estimating the Cost-Effectiveness of OnabotulinumtoxinA for Neurogenic Detrusor Overactivity in the United States. Carlson JJ, Hansen RN, Dmochowski RR, Globe DR, Colayco DC, Sullivan SD Clin Ther. 2013 Mar 20. PMID: 23522658. Abstract CommentRecommendBookmarkWatch